Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Naloxegol 25mg tablets
0106060B0AAABAB
|
Naloxegol | Naloxegol | Gastro-Intestinal System | 10,786 |
|
Naloxegol 12.5mg tablets
0106060B0AAAAAA
|
Naloxegol | Naloxegol | Gastro-Intestinal System | 1,977 |
|
Moventig 25mg tablets
0106060B0BBABAB
|
Moventig | Naloxegol | Gastro-Intestinal System | 337 |
|
Moventig 12.5mg tablets
0106060B0BBAAAA
|
Moventig | Naloxegol | Gastro-Intestinal System | 84 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.